HD-PATIENTS WITH ATRIAL FIBRILLATION TREATED ADEQUATELY AND SAFE WITH DOAC BY INDIVIDUAL DOSING USING ROUTINE ANTI-XA DRUG-EFFECT MONITORING: LONG-TERM CLINICAL PRACTICE DATA

被引：0
|
作者：
Brensing, Karl August [1 ]
Raab, Peter [1 ]
Heidkamp, Peter [1 ]
Poege, Uwe [1 ]
机构：
[1] Nierenzentrum Bonn, Dialysis Unit, Bonn, Germany
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO732
引用
收藏
页码：415 / 415
页数：1
相关论文
共 2 条
  • [1] MATCHED CONTROL STUDY ON APPLIED LONG-TERM ANTI-THROMBOTIC THERAPIES AND CLINICAL OUTCOME OF ATRIAL FIBRILLATION IN HD-PATIENTS BASED ON GERMAN NETWORK DATA
    Brensing, Karl August
    Ochsmann, Anna
    Omran, Heyder
    Lonnemann, Gerhard
    Reichel, Helmut
    Duttlinger, Johannes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I870 - I871
  • [2] ANTITHROMBOTIC THERAPIES AND CLINICAL OUTCOME OF ATRIAL FIBRILLATION IN ADULT HD-PATIENTS: LARGE LONG-TERM COHORT STUDY ON GERMAN NETWORK DATA.
    Brensing, Karl August
    Ochsmann, Anna
    Omran, Heyder
    Lonnemann, Gerhard
    Reichel, Helmut
    Duttlinger, Johannes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 117 - 117
1